Evidence Hub

P0170 Escin Alleviates the Experimental DSS-Induced Colitis by Remodeling Macrophage Polarization Through NF-κB Signaling

Z. Zhou, S.-Y. Chen, H. Nie, F. Chen, F. An, Q. Zhan, J. Sun

Journal of Crohn's & Colitis, 2026

1 citation

Abstract

Escin is a triterpenoid saponin extracted from the dried mature seeds of Aesculus wilsonii Rehd. (Hippocastanaceae). This study aimed to investigate the effects of Escin on dextrose sodium sulfate (DSS)-induced mice.

Our investigation included in vivo assessments of Escin’s therapeutic potential against DSS-induced colitis through efficacy and safety evaluation. Potential targets of Escin were identified using a network pharmacology approach combined with molecular docking. Additionally, flow cytometric analysis was performed to evaluate immune cell subsets and macrophage polarization within spleen and colon tissues. In vitro experiments utilized lipopolysaccharide (LPS)-stimulated RAW264.7 cells and bone marrow-derived macrophages (BMDM) to elucidate relevant mechanisms.

Escin demonstrated significant therapeutic potential against DSS-induced colitis by ameliorating disease symptoms, restoring intestinal barrier integrity, and reducing proinflammatory cytokine production in colonic tissues. Furthermore, it demonstrated favorable hepatorenal safety profiles. Network pharmacology analysis identified the NF-κB signaling pathway as a central target, and molecular docking further revealed strong binding affinities between Escin and key proteins involved in NF-κB signaling, such as IKBKB and TNF. Flow cytometry revealed that Escin exerted immunomodulatory effects in vivo by suppressing pro-inflammatory M1 macrophages while promoting anti-inflammatory M2 macrophages within colon…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free